This article is more than 5 years old. Information may no longer be current.

Oncology Drugs in the Pipeline

Issue: May 25, 2013

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

HemOnc Today presents the most recent information about oncology drugs in the pipeline. Drugs listed here are in phase 2 or phase 3 development for a variety of indications. Clinicians can use this chart as a quick reference to learn about the status of those drugs that may be clinically significant to their practice.

To see the perspectives, please go to this link: http://www.healio.com/hematology-oncology/practice-management/news/online/%7B128aa2d8-f81d-45b4-8d5b-bade88136371%7D/clinicians-offer-insights-into-promising-drugs-in-the-pipeline.

Source: Information in this chart was compiled from the Pharmaceutical Research and Manufacturers of America, NIH (www.clinicaltrials.gov), corporate websites and the databases of HemOnc Today. The publisher or editors do not assume responsibility for any errors or omissions.